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Abstract
Background: 20% of women living in the UK have a hysterectomy during their lifetime, levels are
higher in the USA, making it one of the most commonly performed major surgical procedures.
Understanding of the indications for hysterectomy and of the rationale for follow-up of women
post hysterectomy is currently limited. Guidelines concerning follow-up by means of vaginal vault
cytology tests exist but these are not based on 'gold standard' evidence. Furthermore, the extent
to which current practice reflects these guidelines is unclear. This study aims to determine the
factors associated with variability in hysterectomy rates and subsequent follow-up after surgery by
use of the vaginal vault smear cytology test.
Methods/Design: All women resident in the West Midlands region, of the United Kingdom, who
had a hysterectomy operation between 1st April 2002 and 30th March 2003 will be identified from
the Hospital Episodes Statistics database which also contains proxy data on deprivation status,
derived from postcode and self declared ethnicity. These data will be linked to regional cervical
screening records for each woman and histopathology laboratory records from the relevant
hospitals. Study objectives are to describe: Indications for the hysterectomy operation, histology at
hysterectomy, subsequent follow-up by use or non-use of vaginal vault cytology tests and variation
between histological groups. Additionally the data will be categorised according to a woman's
cytology screening history prior to surgery (i.e. always normal, borderline, resolved abnormalities,
CIN etc) and these different groups compared. Variations in these outcomes according to age,
deprivation and ethnic group will also be examined. Analysis will be undertaken using SPSS.
Discussion: This study will clarify patterns of current practice in one large English region and
determine whether this practice reflects existing guidelines. The study will also strengthen the
evidence base for future guidelines.
Study registration: National Research Register N0138173331
Background
Surgical removal of the uterus (womb) is a 'hysterectomy'
operation; over 98% women who have their uterus
removed also have the cervix uteri or 'neck' of the uterus
removed at the same time, a total hysterectomy[1]. This
leaves the vagina as a pouch with a blind end at the site of
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amputation of the cervix. There were around 39,000 hys-
terectomy procedures undertaken in the UK in 2005 [2], a
cumulative lifetime incidence of 20% [3,4], making it one
of the most frequently performed major surgical proce-
dures [5].
The most common indication for a hysterectomy is men-
orrhagia which accounts for 46% of all hysterectomies.
Prolapse accounts for a further 20%, and fibroids (or lei-
omyoma) another 18%–21% [6]; 90% of hysterectomies
are performed for benign or noncancerous conditions [7].
Hysterectomy is inversely associated with social class and
education with women from lower social classes being
more likely to have a hysterectomy [3]. Several large
cohort studies have examined the indications for hysterec-
tomy in the UK, however none has published details of
how these women are followed-up or the cost-effective-
ness of the vaginal vault cytology test (known colloquially
as a 'vault smear') in the population [3,4,6]. A vault smear
is a cytological sample taken from the blind end of the
vagina; the vault smear is used a means of identifying
recurrent cervical cancer or the development of vaginal
neoplasia. Total hysterectomy is usually a reason for ceas-
ing recall from the routine cervical screening programme,
as the cervix is no longer present.
No international consensus exists on the appropriate
extent of cytological screening in women who have under-
gone hysterectomy, as evidence for the appropriate use of
vaginal vault smears post-hysterectomy and the optimum
period of follow-up is sparse. The majority of published
studies recommend the use of vaginal vault smears in the
follow-up of women who have had a hysterectomy subse-
quent to the diagnosis of an invasive tumour of the cervix
uteri, or where invasive disease is an incidental finding at
hysterectomy [8-12]. A systematic review of the literature
[13] could identify no robust controlled trials that estab-
lish the value of the follow-up, by vault smears, for
women who have had a hysterectomy for benign indica-
tions. The available evidence does, however, suggest that
the vault smear test has a very low positive predictive
value when used as a screening tool in the absence of
symptoms or clinical signs [8,9,14]. Therefore, most com-
mentators recommend that vault smears for post-hyster-
ectomy follow-up are only required for women who have
had a histological diagnosis of Cervical Intraepithelial
Neoplasia (CIN) III or frank malignancy [10-12]. Some go
as far as to say that even in women with previous cytolog-
ical abnormality, vault smears should be limited to those
who present with symptoms or in whom an abnormality
is detected clinically [15].
Currently the UK National Health Service Cervical Screen-
ing Programme (NHSCSP) guidelines for the use of vagi-
nal vault smears are: [16,17]
(i) for women on routine recall for at least 10 years prior
to hysterectomy, and no CIN in the histopathology sam-
ple at hysterectomy, no vault cytology is required.
(ii) for women with less than 10 years' routine recall and
no CIN at hysterectomy, a sample should be taken from
the vaginal vault six months after surgery and there should
be no further cytology follow-up if it is negative.
(iii) for women with completely excised CIN at hysterec-
tomy, a sample should be taken from the vault at 6 and 18
months after surgery and there should be no further cytol-
ogy follow-up if both samples are negative.
(iii) for women with incomplete or uncertain excision of
CIN follow-up should be conducted as if the cervix were
still in situ (i.e as for low and high risk follow-up).
(iv) women who have undergone a hysterectomy but
where the cervix is not completely excised are treated as if
the cervix were still present and as such they remain in the
normal cervical screening programme.
In a survey of primary healthcare professionals in South
Birmingham, UK, half of all vault smear tests were con-
ducted in the primary care setting but primary healthcare
professionals' knowledge about the role of the test was
poor [18]. Professionals whose knowledge about the test
was best, performed the test least often, and only one sig-
nificant abnormality was detected in over 5,000 vault
smear specimens [18]. However, there is no recent reliable
data on the patterns and variability in vault smear follow
up and the extent of compliance with the national guide-
lines is unknown.
No large-scale population studies have been undertaken
to establish the actual patterns of follow-up, by use of
vault smear tests, after hysterectomy. One American study
compared the results of vault smears with cervical smears,
in matched controls, and noted that there was a signifi-
cantly reduced risk of test abnormality in those followed
up post-hysterectomy [19]. Vault smear tests undertaken
in asymptomatic women can have a high false positive
rate thus reducing the usefulness of the test [8]. Large-scale
national cohort studies have reported on the socioeco-
nomic distribution of patients undergoing hysterectomy
[4] and the distribution of hysterectomy type (vaginal ver-
sus abdominal) [6], but none has examined the socioeco-
nomic distribution of the histology results at surgery and
the socioeconomic distribution of any subsequent follow-
up by means of vault cytology.BMC Women's Health 2008, 8:6 http://www.biomedcentral.com/1472-6874/8/6
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No international consensus exists as to the most appropri-
ate follow up by vault smear test after hysterectomy [18];
the UK guidelines are not based upon 'gold-standard' evi-
dence [16,17]. With the increasing pressure on diagnostic
and treatment services, the evaluation of diagnostic serv-
ices and identification of inappropriate testing are neces-
sary prerequisites to improving the efficiency of service
provision. Thus there is a need for an adequately powered,
population based study to consider the issue of hysterec-
tomy follow up, the outcome of which may be used to
inform national guidelines and encourage the teaching of
best practice.
Key objectives
- Estimate age and socioeconomic specific incidence rates
for hysterectomy, in the West Midlands.
- Describe indications for hysterectomy in West Midlands.
- Describe variations in incidence and establish those fac-
tors associated with variability.
- Establish the current pattern of follow-up after hysterec-
tomy by means of vaginal vault cytology test.
Methods/Design
Study design
This retrospective population-based analysis of routinely
collected data will link data, from three key sources and
hence enable us to address the study objectives. Figure 1
illustrates the main stages of the study.
Hospital episode statistics (HES) is the national statistical
data warehouse for England of the care provided by NHS
hospitals and for NHS hospital patients treated elsewhere.
It is the data source for a wide range of healthcare analysis
for the NHS, Government and many other organisations
and individuals. For this study HES will be used to iden-
tify the population of women having a hysterectomy dur-
ing the 2002 – 2003 fiscal year (1 April 2002 – 30 March
2003). These women's cervical screening history records
will be obtained from the local health authority cytology
databases; complete records of cytology results for all
women who have had cervical screening within a local
catchment area, ten such areas cover the West Midlands
Health Authority region. All these cytology databases use
the same suite of software and contribute to national sta-
tistics to ensure uniform reporting. These data will be
linked and pseudo-anonymised to just NHS number: A
national, unique, ten-digit identifier that makes it possi-
ble to share patient information across the whole of the
NHS) then supplemental data about specific diagnosis
and laboratory advice will be added from hospital pathol-
ogy laboratory records [20]. The dataset will be fully ano-
nymised to ensure patient confidentiality.
Selection and exclusion criteria
The cohort will include all women resident in the West
Midlands region who had a hysterectomy operation dur-
ing the defined study period.
Population
The West Midlands conurbation of 5.2 million inhabit-
ants covers a very diverse population: It includes urban,
suburban and rural areas ranging from some of the most
to the least affluent wards in the country [21]. This repre-
sents a 10% sample of the population of England and
Wales, (11% of England) and has, on average, a similar
age, sex and socioeconomic profile to the UK as a whole
[22].
Black and minority ethnic groups make up 11.3% of the
West Midlands population, however the range within the
region is quite striking with the 'Birmingham' Local
Health Authority recording 29.6% of persons classifying
themselves as being of black or minority ethnic group
(second only to London) but the 'Staffordshire Moor-
lands' Health Authority figure is only 0.7% [22].
Study design Figure 1
Study design.
HES Data:  
All Hysterectomy operations, 
W Mids, 2002-03. 
Cytology Records: 
Entire screening 
history, all results for 




records:  Data about 
operation, other 
pathologies
Unique database: Women's 
hysterectomy details plus entire 
cytology screening history, operation 




Analysis:  Descriptive analysis of data, 
logistic regression analysis of factors 
associated with follow-up by vault smear test.  
Subgroup analysis by histology at 
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Study methodology
The study depends upon the extraction of data, from three
separate routinely collected datasets, which will then be
combined into a relational database (Microsoft Access
2007) in a format suitable for analysis and fully ano-
nymised. Table 1 summarises all the data items to be
requested and those that will be used to facilitate data
linkage between the three databases.
Data sources
The Hospital Episode Statistics (HES) dataset is managed
by Northgate Information Solutions and access to sensi-
tive confidential information requires permission to be
granted by their security and confidentiality advisory
group (SCAG) [23]. It is from this database that hospital
in-patient data will be extracted: Data about all hysterec-
tomy operations will be requested and then categorised as
'total' and 'sub-total' hysterectomies with the sub-total
operations being excluded after verification.
The NHS Information Authority (NHSIA) has control
over the Exeter database: The NHSIA is a 'special health
authority' formed in 1999, the 'Exeter' system or now,
more correctly the 'National Health Applications and
Infrastructure Service' (NHAIS) is an integrated suite of
software used by all health authorities at a regional level
for holding administrative details of patients on GPs lists
and used to manage patient registration, GP payments,
breast and cervical screening programme [24]. The NHSIA
will provide the following dataset: All women, residing in
the West Midlands region and identified from the HES
dataset, who have ever had a smear test (cervical or vagi-
nal).
Currently there are 17 cytopathology units in the West
Midlands region and over 20 units where hysterectomy
operations are performed routinely. To obtain accurate
data concerning the histology at hysterectomy, it will be
necessary to access the histopathology records from some
hospitals directly. Since 1995 all histopathology laborato-
ries in the West Midlands have had stand alone, compu-
terised databases of their clinical records and thus data
extraction will not require access to patient case notes, just
to the electronic histopathology and cytopathology
records.
Once matching and merging of all three data sets is com-
plete, all data will be anonymised to the level of unique
study identifier, age at hysterectomy and deprivation
index; thus NHS number, surname, date of birth and post-
code will be replaced with less identifiable indices.
The whole project was registered on the National Research
Register in December 2004 entry: N0138173331. The
approvals of both Multi Research Ethics Committee
(MREC) and Patient Information Advisory Group (PIAG),
have already been granted (MREC – West Mids MREC
Approval granted on 27th April 2005 Ref: 05/MRE07/27,
PIAG Full approval – 7th March 2006 Ref: 4-05(e)/2005).
SCAG of HES granted approval for access to their data on
11th April 2006, Ref: ET0693.
Ethical issues
This project justifies the use of confidential patient data
because the likely benefits to society outweigh the impli-
cations of that transient loss of confidentiality. The out-
come of this research may have significant implications
for the general population of women thus it may be
argued that it is in the public's best interests for the
Table 1: Summary of extracted data and derived data items to be obtained from the three sources.
Hospital Episode Statistics (HES) 'Exeter' Cervical Screening data Local Hospital Histopathology data
Identifiers for 
linkage
NHS Number, date of birth, postcode 
of home address.
NHS Number, date of birth, postcode 
of home address.
NHS Number.
Data items Ethnicity, dates of hysterectomy 
operation, admission and discharge, 
surgical operation code(s) OPCS, 
diagnosis code(s) SNOMED 
morphology, hospital, consultant, GP 
and PCT of residence.
Dates of all smear tests, results of 
those smear tests and recommended 
follow up, details of smear taker, 
registered GP, current cervical 
screening status and date of death 
(where applicable).
Details of histology at hysterectomy, 
details of all specimens removed, details 
of results of analysis (morphology or 
diagnosis codes), full details of smear 
tests processed at the laboratory.
Data to be thus 
derived or 
calculated
Deprivation score (IMD), duration of 
stay, diagnostic grading of operation 
(benign vs pre-malignant or malignant 
disease), age at surgery.
Deprivation score (IMD), scoring of 
screening history using algorithm, 
whether any vault smears undertaken 
(also using operation date from HES).




Request full data on all West Midlands 
resident women who had a 
hysterectomy during the year, 1st April 
2002 to 30th March 2003. Requires 
approval of HES security and 
confidentiality advisory group.
Request full cervical screening histories 
on all women identified in HES 
database. Requires individual 
permission from each of 10 database 
controllers.
Request full histopathology records on all 
women with NHS numbers identified in 
HES. Requires permission from each of 
17 hospitals ethics committees and heads 
of department.BMC Women's Health 2008, 8:6 http://www.biomedcentral.com/1472-6874/8/6
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research to be undertaken. There is no intention to feed
information back to the individuals involved or take any
decision that affects them. There are no practicable alter-
natives to access patient data of this quality that would be
of equal effectiveness. Confidentiality has been planned
from the outset of this study, and data will be anonymised
as soon as is practicable after data validation has taken
place.
Power calculation/justification of sample size
This is a pragmatic sample of all women in the West Mid-
lands Region who underwent a hysterectomy operation
but sample size calculations were undertaken during pro-
tocol development to ensure the study will have sufficient
power to detect important differences.
The key groups of women are specified by their histology
result at the time of surgery (benign/cervical intraepithe-
lial neoplasia (CIN)/malignant) as this determines their
recommended follow up according to national guide-
lines. The data in Table 2 were used to provide the esti-
mated proportions on the basis of previous research by
the authors (Stokes-Lampard H, Wilson S, Waddell C,
Bentley L, Vaginal vault smears: 10-years of data from a
tertiary centre (Birmingham Women's Hospital NHS
Trust), awaiting publication.)
Assumptions
▪ 4,500 hysterectomies annually in West Midlands.
▪ 80% of hysterectomies undertaken for benign indica-
tions
▪ 10% for CIN
▪ 5% for cancer
▪ 5% will sub-total hysterectomies and excluded from
analysis (approximately 225 cases excluded).
For the benign histology group, a sample of 1,800 women
will be sufficient to estimate prevalence of follow up to
within +/-1% (95% CI); for the CIN and cancer groups the
estimate would be to within +/-4% (95%CI). Thus the
expected sample should be more than adequate and does
not need to be expanded further.
Analysis
Will be undertaken using SPSS for Windows statistical
software, with queries in Microsoft Access 2003® used to
produce descriptive data. A substantial amount of descrip-
tive analysis of the data will be undertaken i.e. frequency
distributions, cross tabulations and simple proportions,
much of which will be amenable to visual formats.
Comparison of the whole study population with the West
Midlands and England populations (2001 census data)
with respect to Index of Multiple Deprivation [22], age,
and ethnicity will be undertaken initially and the results
tabulated. Then age-specific incidence rates (5-year age
bands) for hysterectomy will be calculated.
Pre specified analysis will be used to describe and explore
those factors potentially affecting variability within the
three main research areas i.e. i. Indications for hysterec-
tomy, ii. duration of hospital stay after hysterectomy and
iii. follow up after hysterectomy by means of the vaginal
vault smear cytology (vault smear test).
Hospital diagnosis (obtained from HES records) will be
used as a proxy for indication for hysterectomy. Indica-
tions for hysterectomy will be explored with respect to
deprivation score, age, ethnicity and hospital where sur-
gery took place. Duration of hospital stay will be
described and explored with respect to age, ethnicity and
deprivation score. Each of these will be considered further
by histology type; benign, CIN (further subdivided into
CIN I, II & III) and malignant. Pre-hysterectomy cervical
cytology data will be explored with respect to age, depri-
vation and ethnicity. This data will be coded according to
'per protocol' and 'non-protocol' patterns, according to
UK guidelines, using an algorithm constructed by the can-
cer registry in the West Midlands, this is to ensure stand-
ardised results to facilitate future analysis. Post-
hysterectomy vault cytology will be explored with respect
to age, histology type, deprivation and ethnicity. Most of
Table 2: Estimated numbers of women in each histology category
Sub-Total* (Excluded) Benign CIN All Cancers Totals
Not followed up VS N/A 3240 90 23 3,353
90% 20% 10%
Followed-up VS N/A 360 360 202 922
10% 80% 90%
Totals 225 3600 450 225 4,275
5% 80% 10% 5% (95%)*
* with 5% excluded for being sub-total operations.BMC Women's Health 2008, 8:6 http://www.biomedcentral.com/1472-6874/8/6
Page 6 of 7
(page number not for citation purposes)
this descriptive analysis will be explored using χ2 and t-
tests as appropriate.
Multiple regression analyses will aim to determine the rel-
ative importance of those factors (i.e. age, deprivation
index, hospital of procedure and ethnicity) on the out-
comes of interest.
Finally, differences in the rates of vault smear cytology
between the different histology sub-groups will be further
explored using Kaplan-Meir survival analysis. The sub-
groups will be compared with national guidelines to
establish compliance.
Outcome measures
- Hysterectomy rates: Age and deprivation index standard-
ised rates; histology, consultant and unit specific rates.
- Proportion of women who have smear tests that undergo
a hysterectomy procedure by histology and also by age,
deprivation index, hospital and indication for surgery.
- Proportions of those women having a hysterectomy
which results in the histology being reported as benign/
CIN/malignant.
- Proportion of those having a hysterectomy that are fol-
lowed up by vault smear tests, with respect to histology
group (benign/CIN/malignant), age, deprivation index,
hospital, origin of test (primary or secondary care) con-
sultant and indication for surgery.
- Analysis of over/under use of vaginal vault smears with
respect to current national guidelines.
Discussion
Pilot work suggests that too many vault smear tests are
probably being undertaken and that this test has poor sen-
sitivity to detect disease in low risk women. These findings
fit with some published work but there is a dearth of high
quality research in this area.
This research will establish which women are currently
having hysterectomy operations and determine when
vault smear cytology tests are being done, both in terms of
time elapsed post-operatively and histological indication
for the test. Thus, compliance with current guidelines will
be established and evidence to support the development
of future guidelines will be generated.
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